Ribomic

RIBOMIC develops molecularly targeted pharmaceutical drugs using RNA aptamers. The co-discovery division earns the alliance partner's research expenses for the shared part of co-discovery business with alliance pharmaceutical companies researching aptamer pharmaceutical....